Why GLP-1s Could Be Biggest Brug Breakthrough Ever
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Why GLP-1s Could Be Biggest Brug Breakthrough Ever
-
ナレーター：
-
著者：
For centuries, the dream of effortless weight loss has been chased through fad diets and herbal decoctions, but a modern cultural transformation is finally rewriting the rules.
In this episode, we go inside the phenomenon of GLP-1 receptor agonists that are moving beyond social media buzz to reshape entire industries.
We explore the science of how these medications mimic the glucagon-like peptide-1 hormone to regulate appetite and insulin, transforming obesity from a perceived personal failure into a treatable medical condition.
The impact stretches far beyond the pharmacy counter. We examine the "ripple effect" on the global economy: from gym cultures pivoting to strength training to combat "Ozempic butt," to the "food industry tremors" as giants like Nestlé and Walmart adapt to a world of shrinking appetites.
Discover the startling "weight reduction" math for airlines, where even a 10-pound drop per passenger could save millions in annual fuel costs.
As we look toward a future of dual and triple agonists, we ask the ultimate question: are we witnessing a simple weight-loss trend, or a medical breakthrough that could change the treatment of over 175 different conditions?